After incubation of the parental strain in a cell wall medium containing L-[14C Iglutamic acid, the acid-precipitable radioactivity was lysozyme degradable to a large extent. Radioactive UDP-MurNAc-pentapeptide was isolated from the L-[4C Iglutamic acid-labeled parental cells. After hydrolysis, the label was exclusively present in glutamic acid, the majority of which had the stereoisomeric n-configuration. Compared to the parent the mutant incorporated less L-["4C Iglutamic acid from the wall medium into acid-precipitable material. Lysozyme degraded a smaller percentage of the acid-precipitable material of the mutant than of that of the parent. No radioactive uridine nucleotide precursors could be isolated from the mutant under these conditions. Attempts to identify the enzymatic defect in this mutant were not successful. The activity of UDP-MurNAc-L-Ala: -glutamic acid ligase (ADP; EC 6.3.2.9) (n-glutamic acid adding enzyme) is not affected by the mutation. Possible pathways for n-glutamic acid biosynthesis in E. coli B are discussed.
In recent years many mutants impaired in the biosynthesis of uridine-5'-diphosphate-Nacetyl-muramyl-L-Ala-D-Glu-meso-diaminopimelic acid-D-Ala-D-Ala (UDP-MurNAc-pentapeptide) have been identified (8) . In the collection of temperature-sensitive lysis mutants under study in our laboratories, no mutants were found that required D-glutamic acid for growth (5) . Recently W. Messer isolated a D-glutamic acid auxotroph of Escherichia coli B (2) . Some properties of this mutant are described in the present paper. Unfortunately we did not succeed in identifying the enzymatic defect in this mutant.
MATERIALS AND METHODS
Bacterial strains. E. coli B/r, F-(relevant markers including leu, pro, trp, his, arg, thy, met, lac, gal, strA, hsrK, and hsmK) and its n-glutamate-requiring mutant were obtained from W. Messer, Max-PlanckInstitut fur Molekulare Genetik, Berlin, Germany (2) .
Growth conditions. The cells were grown at 37 C 'Present address: University of Connecticut Health Center, Department of Microbiology, Farmington, Conn. 06032. in CGPY medium (4) containing salts, 0.5% glucose, peptone, and yeast extract. D-Glutamic acid (50 gg/ml) was supplemented if necessary. The optical density of bacterial cultures, determined at various times, was measured in a Unicam-SP600 spectrophotometer at 660-nm wave length. Yeast agar (4) was used as the solid medium.
Murein synthesis. Exponentially growing cells were harvested and then washed with and suspended in the cell wall synthesis medium CWSM-I, which contains glucose, minimal medium salts, chloramphenicol, uracil, and cell wall amino acids. After LUGTENBERG, WIJSMAN, AND VAN ZAANE was necessary to omit unlabeled L-glutamic acid (usually 120 ,g per ml) from CWSM-I. The concentration of L-alanine was 50 mg/liter. Incorporation of the radioactivity in murein was tested by measuring the lysozyme-degradable fraction of the acid-precipitable material.
Degradation with lysozyme. After incubation in CWSM-I, 2.0 ml of the suspension was cooled and washed twice with and suspended in one volume of 10-' M tris(hydroxymethyl)aminomethane (Tris)-hydrochloride, pH 7.0. After ultrasonic disintegration (4), the suspension was heated for five min at 100 C, cooled, and incubated with and without lysozyme (100 jg/ml) for one hour at 37 C. The acid-precipitable radioactivity of 0.2 ml of the washed cell suspension before and after lysozyme treatment was determined. Under these conditions between 20 and 40% of the murein was found to be resistant to lysozyme treatment (4) .
Uridine nucleotides. Accumulation and purification of reference uridine nucleotides was carried out as described previously (5, 9) , except the accumulation of UDP-MurNAc-pentapeptide. This nucleotide was accumulated in Bacillus cereus T growing under vigorous aeration at 37 C in CGPY medium. When the optical density was 0.7 (0.37 mg [dry wt] per ml suspension), chloramphenicol was added to a final concentration of 100 Ag/ml. Fifteen minutes later, vancomycin (10 gg/ml) was added. After further incubation for 40 min, the cells were cooled and harvested (9) . With this procedure, the yield of crude uridine nucleotides was about 300 ,umol/8 liters of culture, which is many times higher than that obtained with the method described in a previous paper (9) .
Radioactive uridine nucleotide precursors were isolated and identified as described previously (5 was the labeled substrate. This procedure could be used because the racemase activity is about 20 times lower than that of D-alanine: D-alanine ligase (3). All substrates and products were separated by chromatography, detected by autoradiography, and counted. Details of the assay procedures were described previously (3).
For the assay of D-alanine: 2-oxo-glutarate aminotransferase (EC 2.6.1.6; D-alanine aminotransferase) two methods were tested. Method A was the colorimetric determination of pyruvate with salicylaldehyde in alkali, as described by Martinez-Carrion and Jenkins (10) . Either sonically disrupted cells or soluble protein after ammonium sulfate precipitation (3) was used as the enzyme source in a final protein concentration of 2 mg/ml. Ketoglutarate was omitted from the control. The mixtures were incubated for 1 h at 37 C. Method B was a microassay, based on the conversion of radioactive 2-ketoglutarate to gluta- 
RESULTS
Growth characteristics. Parent and mutant cells, growing exponentially in CGPY medium supplemented with D-glutamic acid, were washed with the same medium without Dglutamic acid, resuspended, and incubated at 37 C in CGPY medium with or without Dglutamic acid. The optical density was followed (Fig. 2) . The addition of D-glutamic acid had no influence on the growth of the parent strain. The mutant cells lysed in the absence of D-glutamic acid, whereas in the presence of this amino acid no differences between parent and mutant strains were observed with respect to growth rate and morphology. (14) , the lysis observed under restrictive conditions is probably the result of an impaired synthesis of murein.
Murein synthesis. When temperature-sensitive mutants impaired in murein synthesis were incubated in CWSM-I medium, no significant lysis was observed (5) . However, the D-glutamate-requiring strain, unlike its parent strain, showed considerable lysis under these conditions. Compared with its parent strain, the mutant seemed to be defective in the synthesis of murein (Table 1) . However, the optical density of the mutant culture was decreased by 50% in the course of the experiment (60 min). The decreased incorporation of L-["C]alanine can therefore at least partly be explained by the extensive decrease in optical density. Definite proof for an impaired murein synthesis came from the distribution of the radioactivity among the murein precursors (Table 1) . Whereas the majority of the radioactivity of the precursors of the parent strain was found in UDP-MurNAc-pentapeptide and UDP-MurNAc-dipeptide, virtually all radioactivity of the precursors of the mutant was found in UDP-MurNAc-L-Ala. This result shows that the lysis of the mutant strain in the absence of D-glutamic acid is caused by a defect in murein synthesis. Accumulation of UDP-MurNAc-LAla can be explained either by an altered D-glutamic acid adding enzyme with increased Km for D-glutamic acid or by a defective enzyme in the biosynthesis of D-glutamic acid. No significant differences between parent and mutant strains were found in the activities of the adding enzymes for L-alanine, D-glutamic acid, meso-Dpm, or D-alanyl-D-alanine (data not presented). The mutant strain is therefore defective in the synthesis of D-glutamic acid. It seemed to offer a unique opportunity for study- aCells growing exponentially at 37 C in CGPY medium supplemented with D-glutamic acid were washed with and incubated in CWSM-I medium.
After incubation for 15 min at 37 C, L-["4C]alanine was added to 3.0 ml of the suspension in a final concentration of 2 MCi/ml. After additional incubation for 60 min, the perchloric acid-precipitable activity of duplicate samples of 0.1 ml was determined. At the same time, 2.0 ml of suspension was used to isolate the precursors. Reference cultures without radioactivity were incubated under identical conditions and used to determine the optical density, which was constant for the parent strain and decreased by 50% for the mutant strain.
'Corresponding with 0. The cells of the parent strain were incubated in CWSM-I medium, as described previously, to prevent protein synthesis and therefore to increase the possibility of detecting labeled murein in acid-precipitable material. When unlabeled L-glutamate was omitted from CWSM-I, a good incorporation of exogenous L-["C]glutamate into acid-precipitable material was observed. After hydrolysis of this material followed by chromatography in isobutyric acid-1 M ammonia (5:3; vol/vol), more than 98% of the label was found in glutamate. The effect of the cell wall antibiotic vancomycin (300 Ag/ml) on the incorporation of L[1 C]glutamate and, as a control, of L-["C ]-alanine was studied. After incubation for 2 h at 37 C, the incorporation of L-alanine was inhibited by 41% and that of L-glutamic acid by 26%, suggesting that part, but not all, of the L-glutamate taken up was incorporated into murein.
The idea that label from exogenous L-glutamate was present in murein was checked by testing the sensitivity of acid-precipitable material to lysozyme. Both parent and mutant strains were used. As a control, lysozyme-sensitivity of L-["4C ]alanine incorporated into the cells of the parental strain was tested (Table 2 ). In the controls without lysozyme, about 17% of the activity was degraded. Degradation occurred during ultrasonic disintegration and is probably due to degradation by autolytic enzymes that are not completely inactivated by the heat treatment (4). Normally 20 to 40.% of a Parent and mutant strains were incubated in the wall medium and supplemented with the labeled amino acid (2MCi/ml) as described previously. After incubation for 2 h at 37 C, the perchloric acidprecipitable radioactivity in a sample of 0.2 ml was determined. Another sample (2.0 ml) was centrifuged, washed twice with and resuspended into one volume of 10-4 M Tris (pH 7.0), disintegrated by sonic treatment, and heat inactivated as described previously. Samples we're incubated with and without lysozyme. The acid-precipitable activity of samples of 0.2 ml was determined to measure the fraction of lysozyme-sensitive radioactive material. The sample was taken before sonic treatment and was considered to contain 100% activity. Reference cultures without radioactivity were incubated under identical conditions to measure the optical density, which was found to be equal and constant during the incubation in the wall medium for both strains. Investigation of the stereoisomeric form of labeled glutamate in UDP-MurNAcpentapeptide. The parent strain was incubated in 6 ml of wall medium supplemented with L-["C]glutamate (2 XCi/ml) and van- comycin (300 jig/ml) for 40 min at 37 C. In the presence of vancomycin, the radioactivity of the precursors was twice as high as in its absence. UDP-MurNAc-pentapeptide was isolated by charcoal adsorption and purified by paper chromatography using the solvents isobutyric acid-1 M ammonia (5: (12) . As the specific activity of glutamic acid in the hydrolysate was unknown, various amounts were given as a substrate (Table 3) . We found radioactivity in both UDP-MurNAc-dipeptide and UDP-MurNAc-pentapeptide. This result was expected because all enzymes and substrates necessary to convert UDP-MurNAcdipeptide to UDP-MurNAc-pentapeptide are present in the assay mixture. Depending on the dilution of the hydrolyzed sample, 64.5 to 80% of the input radioactivity is converted by the D-glutamic acid adding enzyme. As not all of the stereoisomeric D-form of the reference DLglutamate is converted under the experimental conditions (in earlier experiments over 50% of its radioactivity could be recovered in the product), it is likely that the labeled glutamic acid of in vivo synthesized UDP-MurNAc-pentapeptide is (nearly) completely present as the D-stereoisomeric form.
Preliminary genetic location of the mutation. Because revertants are easily obtained, the phenotype of the mutant is the result of only one mutation. Judging from the number of prototrophic recombinants in relation to several reference markers in crosses with a number of Hfr strains, the mutation responsible for the D-glutamate requirement is situated on the E. coli genome in the segment between the str marker and the origin of the Hfr H strain (data not presented). Of known murein genes, murA (13) and murB (11) , involved in UDP-MurNAc synthesis, as well as alr (16) , for alanine racemase, have been located in the same region, in contrast to genes coding for the adding enzymes which are located close to the leu marker (15) .
DISCUSSION
The present paper describes a number of properties of a D-glutamic acid auxotroph of Escherichia coli. Under restrictive conditions, the cells show the lysis pattern (Fig. 2) that has been observed for mutants impaired in murein synthesis (5, 6) . Experiments in a cell wall medium (4) showed that less 04C-alanine is incorporated into the murein of the mutant ( Table 1) . The mutant accumulates UDP-MurNAc-L-alanine, indicating that D-glutamic acid either cannot be added or cannot be synthesized. As the D-glutamic acid adding enzyme of mutant and parent were equally active, the latter possibility is more likely. Unfortunately we were unable to show in vitro activity of a D-glutamic acid-synthesizing enzyme in extracts of the parent strain.
We were able to show that exogenous L-["C ]glutamate is partly incorporated into the murein of E. coli (Table 2) where it is present as the D-isomer (Table 3 ). This result indicates that D-glutamic acid can be synthesized from L-glutamic acid. The mutant that is impaired in the synthesis of D-glutamic acid incorporated considerably less exogenous L-glutamate into its murein, indicating that the enzyme (or one of the enzymes) that is involved in the biosynthesis of D-glutamic acid via Lglutamic acid, is defective in the mutant strain. The residual murein synthesis in the absence of D-glutamic acid (Tables 1 and 2 ) indicates either that the defective enzyme is leaky or that its product can also be synthesized in small amounts by another enzyme. The enzyme(s) responsible for D-glutamate biosynthesis remain(s) unknown. If D-alanine is required for D-glutamate biosynthesis, as was assumed by Cota-Robles and Duncan (1), Dglutamate synthesis should be blocked in a L-alanine: D-alanine racemase mutant under restrictive conditions, and accumulation of UDP-MurNAc-L-alanine should then be expected (Fig. 1) . However, Lugtenberg et al. (5) have found that such a mutant accumulates UDP-MurNAc-tripeptide. The possibility that this tripeptide contains L-glutamate instead of D-glutamate is very unlikely because the Lglutamate can hardly be added to UDP-MurNAc-L-alanine (Table 3) . The possibility that D-glutamate is replaced by another amino acid is unlikely as this then should also occur in the D-glutamate requiring mutant, in which accumulation of UDP-MurNAc-L-alanine was found.
